SIDMAP expands with new lab facility
Metabolic profiling company SIDMAP has opened a new laboratory in West Los Angeles, California, US.
Metabolic profiling company SIDMAP has opened a new laboratory in West Los Angeles, California, US.
A new in silico technique for generating enhanced predictions for ADME/Tox research could have new implications in developing novel drug techniques in combating drug-resistant infectious diseases and cancer.
Life Therapeutics has announced the acquisition of Pyramid Biological Corporation in a deal that increases Life Therapeutics presence in the source plasma sector - a market that has nearly doubled, from $125 million (€103 million) to $230 million,...
According to new data, venture capital funding is on a downswing with a demand for acquisitions shifting in the pharmaceutical sector. The news could signal a trend towards the acquisition of compounds, rights, licenses and product lines, rather than...
Scientists have taken a major step forward in autoimmune disease research after the process of T-cell trafficking through the blood and lymph nodes to fight infection was discovered. Controlling this process with drugs offers "enormous potential"...
DSM Pharmaceutical Products has taken full control of its biologics manufacturing unit after buying out its Canadian joint venture partner.
American Pacific Corp has agreed to acquire the assets of Aerojet Fine Chemicals for $119 million (€98m), in a deal which APC said would give it access to 'fast-growing pharmaceutical markets'.
Sigma-Aldrich is reorganising its operating structure, although its fine chemicals unit SAFC will be unaffected by the restructuring.
Merrion Pharmaceuticals has been granted a US patent for a drug delivery technology that improves the transport of medicines across biological membranes.
The European Medicines Agency has published updated guidelines on the use of plastic packaging in pharmaceuticals, in a bid to help packagers select the best and safest materials for their products.